Back to search
Transgender Persons
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Transgender Persons trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Transgender Persons trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary purpose of this research is to determine how gender affirming hormone therapy affects muscle physiology.
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these te…
This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is…
Estrogen-dominant gender-affirming hormone therapy (GAHT) is standard of care for transgender women and gender-diverse individuals and typically consists of est…
Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes…
The goal of this observational study is to understand the factors influencing the well-being and health of transgender and gender-diverse (TGD) individuals unde…
The purpose of this study is to find the highest safe dose of hu5B1-TCO and the best dosing schedule of hu5B1-TCO and 64Cu-Tz-SarAr for finding cancer cells tha…
Primary Objective: Assess disparities in liver health outcomes among transgender individuals on GAHT by evaluating liver function markers (transaminases, bilir…